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1. Introduction
  Radio therapy is an important method to treat malignancy 
nowadays. However, in the treatment process of abdominal 
neoplasms, the radials simultaneously cause serious 
damages to intestinal tract, such as villi damage, mucosal 
erosion, intestinal vascular embolization and fibrous tissue 
proliferation which finally lead to intestinal stenosis[1]. The 
probability of radiation enteritis are increasing gradually 
in China at present, but it is still in lack of effective means 
of preventing and treating acute and chronic radioactive 
enteritis.
  Umbilical cord mesenchymal stem cells (MSCs) have such 
advantages as a variety of sources, easy collection, and 
convenient transportation. Moreover, they can constantly 
proliferate in vitro without losing any functions, which is 
superior to other types of MSCs. Therefore, they become 
an hopeful tool to achieve tissue reconstruction and 
regeneration[2]. In order to provide new clinical therapeutic 
MSCs on acute radioactive enteritis, we observed the 
curative effects of human umbilical cord-derived MSCs in 
rat model of acute radioactive enteritis. 
  
2. Materials and methods
2.1. Reagents
  Mouse antibodies against human CD34-PE, CD45-PE, 
CD29E, CD44PE, CD73E, CD90E, and CD105-PE were 
purchased from Cell Signaling Technology (USA).
2.2. Rats and grouping
  Sixty male Wistar rats (Laboratory Animal Center of 
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Shandong University) with body weight of (200暲20) g were 
divided into six groups randomly, 10 rats in each group, 
which were blank control group, radiation alone group, 
normal saline group, stem cells prevention group and stem 
cells treatment group, and glutamine treatment group.
2.3.Establishment of rat model
  The rat model of acute radioactive enteritis was established 
as described previously[3,4]. The rats were put into about 
2 cm thick plastic foam boxes which could not block 
radioactive radials. Using Elekta Precise linear accelerator 
(X-rays, Sweden), the irradiation was performed under 
the following conditions: source-skin distance, 120 cm; 
absorbed dose rate, 300 MU/min; radiation field, 10 cm 暳20 
cm; X-ray energy, 6 mV; and total amount, 8 Gy.
2.4. Culture of human umbilical cord-derived MSCs
  
  The human umbilical cord-derived MSCs were cultured 
in vitro as previously described[5]. Umbilical cord of the 
healthy neonatal (about 30-40 cm) was selected in a sterile 
environment, put into stroke-physiological saline solution 
containing 0.1% penicillin-streptomycin, and rinsed in 75% 
(v/v) ethanol. Then it was cut into 1.5-2.0 cm short segments 
with surgical scissors. After the umbilical cord skin and 
artery vessels were removed, the residue was washed with 
normal saline 2-3 times. The obtained umbilical cord was 
mince up and transferred into a centrifuge tube. Later, two 
volumes of 2 mg/L collagenase type I and 100 毺L of 0.1% 
penicillin-streptomycin were added, followed by overnight 
digestion in a 37 曟 incubator. The next morning, an equal 
volume of 2.5 mg/L trypsin solution containing 0.5 g/L EDTA 
was added for further digestion at 37 曟 for 30 min. After the 
digestion, the product was diluted about 8 times with normal 
saline, mixed well, and centrifuged at 3 000 r/min for 20 min. 
Following the removal of the supernatants, the yielded pellet 
was suspended with normal saline and centrifuged at 2 000 r/min
for 10 min. After the supernatants were discarded again, 
the cells were re-suspended in an appropriate amount of 
culture medium, inoculated into culture bottles at a density 
of 1暳10
6 living cells/cm2, and incubated in a 37 曟 incubator 
containing 5% (v/v) CO2. When the cell layer covered over 
90% area of the bottle, the digestion was performed using 
0.5 g/L EDTA-containing 2.5 mg/L trypsin solution and PBS 
which were mixed in a volume ratio of 1:4. Fresh medium 
was added to stop digestion when most cells became round. 
The cell suspension was then centrifuged at 1 500 r/min 
for 10 min. The yielded cell pellet was diluted with an 
appropriate amount of culture medium and counted under 
TCS-SPZ fluorescent inverted confocal microscopy (Leica, 
Germany). Finally, the cells were inoculated at a density of 
3 000-6 000/cm2 and cultured in a 37 曟 incubator containing 
5% (v/v) CO2. Generally, the first five generations were better 
for use. 
2.5. Isolation of stem cells by flow cytometry
  The human umbilical cord MSCs were collected as 
described above. The cell pellet was suspended in PBS to 
obtain single cell suspension. Then each centrifuge tube 
containing 50 毺L of the single cell suspension was added 
15 毺L of mouse antibodies against human CD34-PE, 
CD45-PE, CD29E, CD44PE, CD73E, CD90E, and CD105-PE, 
respectively. Following incubation at room temperature in 
dark for 30 min, 1 mL PBS was added. After centrifugation 
at 1 500 r/min for 6 min, the supernatant was removed 
and the pellet was rinsed in 2 mL PBS by centrifugation at
1 500 r/min for 6 min again. Finally, the cells were re-
suspended in 400 毺L PBS and the targeted human umbilical 
cord MSCs were isolated using FACSCanto II flow cytometry 
(BD Medical Equipment Co., Ltd).
2.6. Therapeutic test
  The rats with acute radioactive enteritis in the stem cells 
prevention group were administrated with 0.4 mL human 
umbilical cord MSCs suspension at a dose of 1暳10
6 cells/kg 
via tail vein 24 h before the radiation, while those in the stem 
cells treatment group were given the stem cells in the same 
way after 24 h post the radiation. Those rats in the normal 
saline group were given 0.4 mL normal saline via tail vein 
after 24 h post the radiation, while those in the glutamine 
treatment group received right vein catheterization after 
abdominal anesthesia and then administrated with 3% 
glutamine nutrition intravenously according to their weight. 
The rats in the radiation alone group and blank control 
group were not given any treatment. 
  The rats were kept in separate cages under the same 
conditions, observed and weighed every 3 days. After 
72 h post the irradiation, one rat was selected randomly 
from each group, and intestine tissues were taken in 
sterile environment and made into slices. HE staining and 
immunohistochemistry applied proliferating cell nuclear 
antigen were conducted for observation under the invert 
microscope. 
3. Results
3.1. Morphological observation of human umbilical cord-
derived MSCs
  
  As observed under the invert microscope, the human 
umbilical cord-derived MSCs became adherent after 1 d 
post the inoculation, and more cells were adherent on day 2. 
After the removal of dead cells and cell debris, the adherent 
cells started to proliferate after 3 days and spread into 
elliptic, short fusiform, polygon and irregular shapes. On 
day 14, cell colonies appeared and almost cover the bottle 
bottom. The cells of the 3rd to 5th generations showed a 
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uniform long shuttle type and arranged into a spiral or radial 
pattern, which is the typical appearance of MSCs. Using the 
flow cytometry, the negative expression of CD34 and CD45 
and positive expression of CD29, CD44, CD73, CD90 and 
CD105 were observed in the isolated MSCs. 
3.2. Clinical manifestations of experimental rats
  On day 1 post the irradiation, the rats in the prevention 
group and treatment group had the best spirits, bright eyes, 
swift response, increased food and water intake, active 
movements and fights with others. They bit the glove when 
we tried to catch them. However, those in other groups were 
somnolent and discharged loose stools. On day 2 post the 
irradiation, the rats in the prevention group and treatment 
group still had better mental status, and no obvious 
changes except loose stools were observed in the rats of the 
glutamine treatment group. Somnolence was observed yet in 
other groups. On day 3 post the irradiation, loose stools were 
found in all groups, especially obvious in the radiation alone 
group. The rats had back furs in various shades of yellow 
as well as exfoliated skin and irregular spotted in tails. The 
best spirits were observed in the rats of the treatment group. 
After 72 h post the irradiation, the number of dead rats was 
1, 2, 1, 0, 1, and 1 in the blank control group, radiation alone 
group, normal saline group, stem cells prevention group, 
stem cells treatment group, and glutamine treatment group, 
respectively. The body weight was not significantly different 
between the groups. 
3.3. Histological changes of experimental rats
  The intestine tissues were taken after 72 h post the 
irradiation. The rats of the blank control group and normal 
saline group had regular morphology of intestinal mucosa 
villi as well as normal size, shape and arrangement of 
mucosa epithelial cells. No hyperaemia, edema and 
infiltration of inflammatory cells were observed in the 
mucosa of these rats (Figure 1A). However, the rats of the 
irradiation group showed radioactive changes in intestinal 
mucosa, as demonstrated by irregular morphology of 
intestinal mucosa villi and abnormal size, shape and 
arrangement of mucosa epithelial cells. Hyperaemia, 
edema, infiltration of acute and chronic inflammatory cells 
and local mucosa anabrosis were seen in the radiated rats 
(Figure 1B). The rats which were given human umbilical 
cord MSCs 24 h before the irradiation had reversed changes 
in the intestine tissues. They showed regular morphology of 
intestinal mucosa villi, mild anabrosis in focal mucosa, and 
slight hyperaemia, edema and infiltration of a small quantity 
of acute and chronic inflammatory cells in some regions of 
the mucosa (Figure 1C). The rats treated with the stem cells 
and those given glutamine 24 h after the irradiation had 
changes of different degrees in the structure of intestinal 
mucosa compared with the blank control group and normal 
saline group (Figure 1D and 1E), except that anabrosis 
and inflammatory cell infiltration to various degrees were 
observed in the treated rats. The immunohistochemical 
observation revealed remarkably increased number and 
proliferation activity of mucosa epithelial cells in the treated 
rats (Figure 2). 
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Figure 1. Intestinal mucosa of rats with acute radioactive enteritis 
after treatment with human umbilical cord-derived mesenchymal stem 
cells (HE staining, 100暳).
A. Blank control group; B. Normal saline group C. Radiation alone 
group; D. Stem cells prevention group; E. Stem cells treatment group; 
F. Glutamine treatment group. 
Figure 2. Immunohistochemical test of the rats of the intestinal 
mucosa of the treatment group (暳100). 
Proliferating cell nuclear antigen is positive. 
4. Discussion
   In recent years, the morbidity of intestinal tumor has been 
at a high level, and radiotherapy has become an important 
method to treat intestinal tumor. However, radiation enteritis 
is also accompanied with the treatment. According to the 
total dose of the radiotherapy, size of radiation field, course 
time and division method, the course of radiation enteritis 
can be divided into acute phase and chronic phase[6,7]. The 
acute radiation enteritis occurs within 1-2 weeks with main 
manifestations like nausea, emesis, stomachache, acute 
diarrhea, and tenesmus, while the chronic radiation enteritis 
generally occurs after several months or years with main 
manifestations like mucous bloody stool, intestinal stenosis, 
anal pendant expansion and even intestinal obstruction. 
  To control symptoms is used to treat acute radiation 
enteritis, and the measures include the obstruent loperamide, 
antispasmodic anisodamine, prostaglandins inhibition agent 
5-aminosalicylic acid, and intestinal mucosa protective 
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agent dioctahedral smectite[8]. Pharmaceuticals adjusting 
the intestinal flora should also be taken at the same time. If 
the conditions are not well controlled, short-term parenteral 
nutrition should be given and changed to enteral nutrition 
later. The measures for the chronic phase include nutritional 
support, enemas, antioxidant and cytoprotective agents, 
Chinese herbal medicines, and operation and hyperbaric 
oxygen therapy if necessary. 
  Stem cell therapy has hypotoxicity or nontoxicity, and 
preferable therapeutic effects can be achieved even if the 
exact pathogenesis of diseases is unclear. Accumulated 
studies have demonstrated that injection of a certain amount 
of MSCs before and after radiation can alleviate radials-
induced damages to intestinal mucosa, effectively heal 
intestinal tract and cure radiation enteritis to a certain 
extent. When in vivo environments are suitable, marrow 
MSCs can replace the necrotic intestinal wall tissues caused 
by radiation, and they also reconstruct tissues[9]. Zhang et 
al certified the colonization and differentiation capacity of 
the genetically modified marrow MSCs towards the intestinal 
tract could be significantly enhanced, and the radioactive 
damages repair could be promoted[10]. However, it is difficult 
to acquire and cultivate marrow MSCs. 
  Human umbilical cord MSCs can be induced to differentiate 
into various types of adult cells, and autologous stem cells 
transplantation does not cause immunologic rejection. In 
this study, we tried to treat acute radiation enteritis using the 
isolated human umbilical cord MSCs. As shown by the HE 
stainning test, anabrosis and inflammatory cell infiltration 
in the intestinal mucosa were observed in all groups except 
in the control. The rats in the radiation alone group had 
the most serious intestinal lesions. These pathological 
changes of the intestinal mucosa were also confirmed by 
the loose stools in clinic. Histological observation revealed 
that the irradiated rats in the prevention group, stem cells 
treatment group and glutamine treatment group had regular 
morphology of intestinal mucosa villi and normal quantity of 
the mucosa epithelial cells, except that slight inflammatory 
infiltration was visible. The rats treated with the stem cells 
24 h after the irradiation had the mildest intestinal changes. 
The results indicate that the intestinal mucosa could repair 
itself with the help of the human umbilical cord MSCs. 
Previous researches also demonstrated that stem cells could 
locate in radioactively damaged intestinal tract and help 
the structural recovery of intestinal tract, thus showing 
therapeutical effects[11,12]. The immunohistochemical tests 
also showed the regeneration of intestinal epithelial cells. 
In addition, although glutamine also help to repair the 
intestinal tract, its therapeutic effects were not as good as 
those of the human umbilical cord MSCs. 
  In summary, we verified the curative effects of human 
umbilical cord MSCs on acute radioactive enteritis in rats. 
The prevention with human umbilical cord MSCs before 
irradiation also showed certain therapeutical effects on 
radicals-induced intestinal damages. A lot of research 
works are required for application of MSCs clinically.
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